Strontium Ranelate Inhibits Osteoclastogenesis through NF-κB-Pathway-Dependent Autophagy

Strontium ranelate (SR) is a pharmaceutical agent used for the prevention and treatment of osteoporosis and fragility fracture. However, little attention has been paid to the effect of SR on alveolar bone remodeling during orthodontic tooth movement and its underlying mechanism. Here, we investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Dongle, Sun, Xuan, Zhao, Yiwei, Liu, Yuanbo, Gan, Ziqi, Zhang, Zhen, Chen, Xin, Cao, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045081/
https://www.ncbi.nlm.nih.gov/pubmed/36978756
http://dx.doi.org/10.3390/bioengineering10030365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045081/
https://www.ncbi.nlm.nih.gov/pubmed/36978756
http://dx.doi.org/10.3390/bioengineering10030365

Ejemplares similares